← Study Library
Systematic review · 2026
Preclinicalcounts toward this tierPeptide Supplements and Their Therapeutic Applications in Sports Medicine
Tewari K, Liu TP, Im C, Hamad C, Petrigliano F, Cheung EC, Kremen TJ Jr · The American Journal of Sports Medicine
Preclinicalcounts toward this tier
Two-thirds of the identified publications were preclinical animal work; human studies were a handful, mostly without robust controls, and showed modest results at best. The authors conclude these peptides should not be recommended as a replacement or adjunct to orthopaedic standard of care.
- Population
- PRISMA scoping review of six marketed peptides — including TB-500 — against bone, fracture, muscle, tendon, ligament, meniscus and cartilage endpoints
- Intervention
- n/a
- Comparator
- n/a
- Limitations
- Scoping review, so no pooled effect estimates or formal risk-of-bias scoring; inherits the heterogeneity of a literature with almost no controlled human data.
Cited by
3 entries reference this study
- TB-500 / thymosin beta-4PRECL.
Peptides → Preclinical & experimental · key study
- BPC-157PRECL.
Peptides → Preclinical & experimental
- GHK-CuPRECL.
Peptides → Preclinical & experimental